company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:04:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,18694284.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:04:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,18694284.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:04:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18694284.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:04:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5216286.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:04:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19010963.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:04:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24227249.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:04:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5532965.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:04:41+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,433184.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:04:41+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,24999.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:04:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-408185.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:04:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5941150.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:04:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5941150.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:04:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5941150.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:04:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5941150.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:04:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25800000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:04:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.23
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:04:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25800000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:04:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.23
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:04:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,26285125.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:04:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.23
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:19:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,22495802.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:19:40+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,22495802.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:19:40+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,22495802.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:19:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5014987.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:19:40+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,38731902.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:19:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,43746889.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:19:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-21251087.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:19:40+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,521742.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:19:40+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,122474.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:19:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-399268.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:19:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-21650355.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:19:40+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-700321.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:19:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20950034.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:19:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20950034.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:19:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-20950034.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:19:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,26200000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:19:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.8
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:19:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,26200000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:19:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.8
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:19:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,26333012.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:19:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.8
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:47:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,27187000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:47:06+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,27187000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:47:06+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,27187000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:47:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4876000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:47:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,24278000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:47:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,29154000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:47:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1967000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:47:06+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,433000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:47:06+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,94000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:47:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-339000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:47:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2306000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:47:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2306000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:47:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2306000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:47:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2306000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:47:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25600000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:47:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:47:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25600000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:47:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:47:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,26536048.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:47:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:04:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,19956579.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:04:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,19956579.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:04:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,19956579.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:04:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6329669.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:04:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,24992754.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:04:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,31322423.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:04:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11365844.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:04:41+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,432975.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:04:41+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,68828.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:04:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-364147.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:04:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11729991.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:04:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11729991.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:04:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11729991.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:04:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11729991.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:04:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,26700000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:04:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.44
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:04:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,26700000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:04:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.44
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:04:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,26567980.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:04:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.44
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:19:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23304788.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:19:40+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23304788.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:19:40+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,23304788.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:19:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5469688.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:19:40+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,29418327.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:19:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,34888015.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:19:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11583227.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:19:40+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,432975.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:19:40+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,71483.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:19:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-361492.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:19:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11944719.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:19:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11944719.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:19:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11944719.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:19:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11944719.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:19:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,26500000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:19:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.45
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:19:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,26500000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:19:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.45
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:19:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,26666332.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:19:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.45
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,22324633.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,22324633.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,22324633.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6043643.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,29892919.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,35936562.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13611929.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,542050.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-234311.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,327000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-449361.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14061290.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14061290.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14061290.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14061290.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,26700000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.52
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,26700000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.52
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,26620278.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.52
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q1,2012-01-01,2012-03-31,2012-05-08 15:47:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,25202000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q1,2012-01-01,2012-03-31,2012-05-08 15:47:06+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,25202000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q1,2012-01-01,2012-03-31,2012-05-08 15:47:06+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,25202000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q1,2012-01-01,2012-03-31,2012-05-08 15:47:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6812000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q1,2012-01-01,2012-03-31,2012-05-08 15:47:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28551000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q1,2012-01-01,2012-03-31,2012-05-08 15:47:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,35363000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q1,2012-01-01,2012-03-31,2012-05-08 15:47:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10161000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q1,2012-01-01,2012-03-31,2012-05-08 15:47:06+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,681000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q1,2012-01-01,2012-03-31,2012-05-08 15:47:06+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,120000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q1,2012-01-01,2012-03-31,2012-05-08 15:47:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-561000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q1,2012-01-01,2012-03-31,2012-05-08 15:47:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10722000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q1,2012-01-01,2012-03-31,2012-05-08 15:47:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10722000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q1,2012-01-01,2012-03-31,2012-05-08 15:47:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10722000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q1,2012-01-01,2012-03-31,2012-05-08 15:47:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10722000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q1,2012-01-01,2012-03-31,2012-05-08 15:47:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,26800000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q1,2012-01-01,2012-03-31,2012-05-08 15:47:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.4
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q1,2012-01-01,2012-03-31,2012-05-08 15:47:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,26800000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q1,2012-01-01,2012-03-31,2012-05-08 15:47:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.4
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q1,2012-01-01,2012-03-31,2012-05-08 15:47:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,26776856.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q1,2012-01-01,2012-03-31,2012-05-08 15:47:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.4
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 07:50:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,21911000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 07:50:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,21911000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 07:50:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,21911000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 07:50:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7666000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 07:50:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28532000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 07:50:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,36198000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 07:50:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14287000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 07:50:44+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,694000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 07:50:44+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,320000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 07:50:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-374000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 07:50:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14661000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 07:50:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14661000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 07:50:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14661000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 07:50:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14661000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 07:50:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27200000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 07:50:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.54
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 07:50:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27200000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 07:50:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.54
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 07:50:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27061435.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 07:50:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.54
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 07:31:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6294000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 07:31:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21495000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 07:31:01+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-46555000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 07:31:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,-18766000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 07:31:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,18766000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 07:31:01+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,533000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 07:31:01+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,170000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 07:31:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-363000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 07:31:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,18403000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 07:31:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,18403000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 07:31:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,18403000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 07:31:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,18403000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 07:31:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32039866.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 07:31:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.57
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 07:31:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,35173223.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 07:31:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.52
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 07:31:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,32300000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 07:31:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.57
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7110000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,40017000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,47127000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-47126000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-417000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,559000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,142000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-46984000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-46984000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-46984000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-46984000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31700000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.33
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31700000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.28
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31711264.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.33
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 15:52:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7430000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 15:52:09+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20231000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 15:52:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27661000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 15:52:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-27661000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 15:52:09+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,335000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 15:52:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,335000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 15:52:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-27326000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 15:52:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27326000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 15:52:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27326000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 15:52:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-27326000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 15:52:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,47900000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 15:52:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.57
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 15:52:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,47900000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 15:52:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.57
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 15:52:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47620147.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 15:52:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.57
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 07:46:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6675000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 07:46:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,26080000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 07:46:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,32755000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 07:46:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-32755000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 07:46:18+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,164000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 07:46:18+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,164000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 07:46:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-32591000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 07:46:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-32591000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 07:46:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-32591000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 07:46:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-32591000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 07:46:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,47900000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 07:46:18+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.68
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 07:46:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,47900000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 07:46:18+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.68
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 07:46:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47915726.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 07:46:18+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.68
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q3,2013-07-01,2013-09-30,2013-11-07 15:50:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7319000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q3,2013-07-01,2013-09-30,2013-11-07 15:50:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,26857000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q3,2013-07-01,2013-09-30,2013-11-07 15:50:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,34176000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q3,2013-07-01,2013-09-30,2013-11-07 15:50:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-34176000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q3,2013-07-01,2013-09-30,2013-11-07 15:50:51+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,238000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q3,2013-07-01,2013-09-30,2013-11-07 15:50:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,238000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q3,2013-07-01,2013-09-30,2013-11-07 15:50:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-33938000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q3,2013-07-01,2013-09-30,2013-11-07 15:50:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-33938000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q3,2013-07-01,2013-09-30,2013-11-07 15:50:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-33938000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q3,2013-07-01,2013-09-30,2013-11-07 15:50:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-33938000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q3,2013-07-01,2013-09-30,2013-11-07 15:50:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,48052939.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q3,2013-07-01,2013-09-30,2013-11-07 15:50:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.71
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q3,2013-07-01,2013-09-30,2013-11-07 15:50:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48052939.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q3,2013-07-01,2013-09-30,2013-11-07 15:50:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.71
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q3,2013-07-01,2013-09-30,2013-11-07 15:50:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47800000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q3,2013-07-01,2013-09-30,2013-11-07 15:50:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.71
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6492000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,26592000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,33084000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-33084000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,159000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,159000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-32925000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-32925000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-32925000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-32925000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,48000000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.68
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48000000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.68
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47936001.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.68
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q1,2014-01-01,2014-03-31,2014-05-06 15:56:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6804000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q1,2014-01-01,2014-03-31,2014-05-06 15:56:09+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,34491000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q1,2014-01-01,2014-03-31,2014-05-06 15:56:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,41295000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q1,2014-01-01,2014-03-31,2014-05-06 15:56:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-41295000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q1,2014-01-01,2014-03-31,2014-05-06 15:56:09+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1139000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q1,2014-01-01,2014-03-31,2014-05-06 15:56:09+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,168000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q1,2014-01-01,2014-03-31,2014-05-06 15:56:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-971000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q1,2014-01-01,2014-03-31,2014-05-06 15:56:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-42266000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q1,2014-01-01,2014-03-31,2014-05-06 15:56:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-42266000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q1,2014-01-01,2014-03-31,2014-05-06 15:56:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-42266000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q1,2014-01-01,2014-03-31,2014-05-06 15:56:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-42266000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q1,2014-01-01,2014-03-31,2014-05-06 15:56:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,48600000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q1,2014-01-01,2014-03-31,2014-05-06 15:56:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.87
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q1,2014-01-01,2014-03-31,2014-05-06 15:56:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48600000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q1,2014-01-01,2014-03-31,2014-05-06 15:56:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.87
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q1,2014-01-01,2014-03-31,2014-05-06 15:56:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,48348767.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q1,2014-01-01,2014-03-31,2014-05-06 15:56:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.87
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:53:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7057000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:53:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28165000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:53:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,35222000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:53:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-35222000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:53:22+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2938000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:53:22+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,136000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:53:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2802000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:53:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-38024000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:53:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-38024000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:53:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-38024000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:53:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-38024000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:53:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,48700000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:53:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.78
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:53:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48700000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:53:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.78
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:53:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,48543853.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:53:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.78
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 15:32:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,160639000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 15:32:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,160639000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 15:32:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,160639000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 15:32:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8042000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 15:32:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,44895000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 15:32:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,52937000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 15:32:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,107702000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 15:32:27+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4537000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 15:32:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,52000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 15:32:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4485000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 15:32:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,103217000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 15:32:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,103217000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 15:32:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,103217000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 15:32:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,103217000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 15:32:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,48632888.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 15:32:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.08
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 15:32:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49735303.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 15:32:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.03
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 15:32:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,49600000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 15:32:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.08
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4356000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4356000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4356000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7382000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,36082000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,43464000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-39108000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1035000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-17000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1052000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-40160000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,183000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-40343000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-40343000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-40343000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,48400000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.79
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48400000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.74
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,48561653.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.79
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 15:44:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4363000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 15:44:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4363000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 15:44:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4363000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 15:44:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8550000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 15:44:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,88428000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 15:44:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,96978000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 15:44:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-92615000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 15:44:27+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,647000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 15:44:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-40000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 15:44:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-687000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 15:44:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-93302000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 15:44:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-93302000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 15:44:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-93302000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 15:44:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-93302000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 15:44:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,48800000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 15:44:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.91
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 15:44:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48800000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 15:44:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.91
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 15:44:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,48939383.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 15:44:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.91
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 15:55:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4880000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 15:55:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4880000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 15:55:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4880000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 15:55:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9410000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 15:55:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,34062000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 15:55:14+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 15:55:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,43472000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 15:55:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-38592000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 15:55:14+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,99000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 15:55:14+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,263000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 15:55:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,164000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 15:55:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-38428000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 15:55:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-38428000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 15:55:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-38428000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 15:55:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-38428000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 15:55:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49076031.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 15:55:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.78
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 15:55:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49076031.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 15:55:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.78
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 15:55:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,49300000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 15:55:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.78
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 15:52:08+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,90743000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 15:52:08+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,90743000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 15:52:08+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,90743000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 15:52:08+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9754000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 15:52:08+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,37729000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 15:52:08+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 15:52:08+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,47483000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 15:52:08+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,43260000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 15:52:08+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,311000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 15:52:08+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,75000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 15:52:08+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-236000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 15:52:08+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,43024000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 15:52:08+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,480000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 15:52:08+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,42544000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 15:52:08+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,42544000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 15:52:08+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,42544000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 15:52:08+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49188443.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 15:52:08+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.85
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 15:52:08+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49764910.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 15:52:08+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.84
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 15:52:08+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,50100000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 15:52:08+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.85
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9080000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9080000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9080000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9351000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,38890000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,48241000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-39161000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,311000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,137000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-174000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-39335000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-180000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-39155000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-39190000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-39190000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49000000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.78
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49000000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.77
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,49083479.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.78
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:00:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9300000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:00:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9300000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:00:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9300000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:00:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10836000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:00:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,39188000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:00:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,50024000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:00:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-40768000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:00:04+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,309000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:00:04+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,413000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:00:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,104000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:00:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-40664000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:00:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-40664000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:00:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-40664000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:00:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-40664000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:00:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49600000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:00:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.82
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:00:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49600000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:00:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.82
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:00:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,49339888.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:00:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.82
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 15:57:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9467000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 15:57:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9467000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 15:57:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9467000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 15:57:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15692000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 15:57:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,52947000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 15:57:17+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-112200000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 15:57:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,-43561000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 15:57:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,53044000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 15:57:17+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,307000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 15:57:17+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,254000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 15:57:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-53000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 15:57:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,52991000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 15:57:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,52991000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 15:57:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,52991000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 15:57:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,52991000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 15:57:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49437062.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 15:57:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.05
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 15:57:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49439537.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 15:57:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.05
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 15:57:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,50500000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 15:57:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.05
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 07:28:00+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 07:28:00+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7120000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 07:28:00+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12814000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 07:28:00+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 07:28:00+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19934000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 07:28:00+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-19934000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 07:28:00+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,305000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 07:28:00+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,741000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 07:28:00+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,436000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 07:28:00+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-19498000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 07:28:00+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19498000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 07:28:00+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19498000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 07:28:00+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-19498000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 07:28:00+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,50000000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 07:28:00+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.39
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 07:28:00+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,50000000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 07:28:00+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.39
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 07:28:00+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,49583776.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 07:28:00+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.39
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,-67000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,-67000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-67000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8571000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14662000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23233000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-23233000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,304000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,607000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,303000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-22930000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22930000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22930000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-22930000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49300000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.45
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49300000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.45
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,49608234.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.45
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 15:36:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6437000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 15:36:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4039000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 15:36:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10476000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 15:36:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10476000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 15:36:15+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,302000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 15:36:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,303000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 15:36:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 15:36:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10475000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 15:36:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10475000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 15:36:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10475000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 15:36:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10475000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 15:36:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49900000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 15:36:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.21
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 15:36:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49900000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 15:36:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.21
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 15:36:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,50423353.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 15:36:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.21
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:27:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6205000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:27:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3901000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:27:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10106000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:27:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10106000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:27:47+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,300000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:27:47+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-6566000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:27:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6866000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:27:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16972000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:27:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16972000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:27:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16954000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:27:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16954000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:27:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49900000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:27:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.34
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:27:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49900000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:27:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.34
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:27:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,50455832.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:27:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.34
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 15:33:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6000000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 15:33:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6000000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 15:33:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6000000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 15:33:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4505000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 15:33:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9338000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 15:33:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13843000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 15:33:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7843000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 15:33:07+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,287000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 15:33:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1026000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 15:33:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,739000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 15:33:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7104000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 15:33:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7104000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 15:33:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7104000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 15:33:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7104000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 15:33:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,50635828.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 15:33:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.14
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 15:33:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,50635828.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 15:33:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.14
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 15:33:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,50700000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 15:33:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.14
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4468000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3552000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8020000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8020000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,121000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,124000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7999000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-700000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7299000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7297000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7297000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,50400000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.14
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,50400000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.14
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,50560195.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.14
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:16:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:16:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3606000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:16:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5911000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:16:35+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:16:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9517000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:16:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9517000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:16:35+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,93000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:16:35+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,159000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:16:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,66000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:16:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9451000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:16:35+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:16:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9451000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:16:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9451000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:16:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9451000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:16:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,52500000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:16:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.18
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:16:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,52500000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:16:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.18
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:16:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,51883570.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:16:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.18
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 07:44:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 07:44:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3386000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 07:44:43+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3749000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 07:44:43+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 07:44:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7135000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 07:44:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7135000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 07:44:43+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 07:44:43+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,172000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 07:44:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,172000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 07:44:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6963000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 07:44:43+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 07:44:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6963000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 07:44:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6963000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 07:44:43+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6963000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 07:44:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,58000000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 07:44:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.12
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 07:44:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,58000000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 07:44:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.12
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 07:44:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,55966910.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 07:44:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.12
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 15:33:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,22000000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 15:33:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,22000000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 15:33:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,22000000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 15:33:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3442000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 15:33:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5379000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 15:33:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8821000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 15:33:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,13179000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 15:33:07+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 15:33:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,202000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 15:33:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,202000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 15:33:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,13381000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 15:33:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,13381000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 15:33:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,13381000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 15:33:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,13381000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 15:33:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,56851811.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 15:33:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.23
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 15:33:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,57638660.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 15:33:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.23
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 15:33:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,58200000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 15:33:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.23
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,146000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,146000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,146000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3814000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4719000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,69000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8602000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8456000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,769000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-533000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,236000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8220000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8220000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8220000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8220000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,56300000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.13
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,56300000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.13
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,55411370.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.13
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:24:23+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2142000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:24:23+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2142000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:24:23+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2142000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:24:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3398000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:24:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5766000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:24:23+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,6761000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:24:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15925000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:24:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13783000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:24:23+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,304000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:24:23+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,289000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:24:23+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-15000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:24:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13798000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:24:23+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-54000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:24:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13744000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:24:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13744000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:24:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13744000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:24:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,57300000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:24:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.24
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:24:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,57300000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:24:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.24
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:24:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,56924914.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:24:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.24
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 07:44:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,257000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 07:44:43+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,257000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 07:44:43+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,257000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 07:44:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3771000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 07:44:43+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6076000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 07:44:43+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,155000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 07:44:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10002000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 07:44:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9745000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 07:44:43+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1087000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 07:44:43+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,318000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 07:44:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-769000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 07:44:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10514000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 07:44:43+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 07:44:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10514000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 07:44:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10514000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 07:44:43+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10514000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 07:44:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,58400000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 07:44:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.18
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 07:44:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,58400000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 07:44:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.18
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 07:44:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,56942033.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 07:44:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.18
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 15:13:37+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,343000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 15:13:37+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,343000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 15:13:37+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,343000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 15:13:37+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3641000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 15:13:37+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7076000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 15:13:37+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,207000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 15:13:37+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10924000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 15:13:37+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10581000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 15:13:37+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1135000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 15:13:37+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,299000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 15:13:37+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-836000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 15:13:37+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11417000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 15:13:37+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 15:13:37+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11417000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 15:13:37+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11417000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 15:13:37+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11417000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 15:13:37+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,57028970.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 15:13:37+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.2
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 15:13:37+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,57028970.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 15:13:37+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.2
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 15:13:37+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,57100000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 15:13:37+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.2
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,307000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,307000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,307000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3479000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8198000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,185000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11862000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11555000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,37000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1116000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-906000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,173000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11382000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-46000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11336000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11382000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11382000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,56700000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.21
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,56700000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.21
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,56983652.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.21
